Find a clinical trial
A clinical trial is a research study that people can join. Some test a new treatment. Some test a new way to use a treatment we already have. Joining one is always your choice.
How to think about a clinical trial covers what taking part involves, when to ask, and what the phases mean.
Talk to your care team before you contact a trial. They know your history and can tell you whether a trial is worth your time. Nothing on this page is medical advice, and we are not part of any trial.
Trials near you
Enter your ZIP code to see open trials with a site within 50 miles. We use your ZIP only to run that search. We do not store it.
This box works for US ZIP codes only. Outside the US, use the country filter below to see trials in your country. It will not tell you how far away they are.
Trials by countries
Showing 478 trials. Trials we know are closed are left out. This list is the brain tumor trials we track, not every trial on ClinicalTrials.gov. The search above looks at all of them.
-
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
From the trial team: Phase 1 will evaluate the safety and tolerability at different dose levels of repotrectinib in pediatric and young adult subjects with advanced or metastatic malignancies harboring anaplastic lymphoma kinase (ALK), receptor tyrosine kinase encoded by the gene ROS1 (ROS1), or neurotrophic receptor kinase genes encoding TRK kinase family (NTRK1-3) alterations to estimate the Maximum Tolerated Dose (MTD) or Maximum Administered Dose (MAD) and select the Pediatric Recommended Phase 2 Dose (RP2D).
-
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
From the trial team: The purpose of the study is to determine the appropriate pediatric dosage and evaluate the pharmacokinetics (PK) and safety of Lutetium Lu 177 Edotreotide Targeted Radiopharmaceutical Therapy (RPT) as a monotherapy or following standard of care (SoC) in participants ≥2 to \<18 years of age with somatostatin receptor (SSTR)-positive tumors.
-
Testing one drug, alone or with a second drug, for HER2-low breast cancer that has spread to the brain
This trial tests a cancer drug, by itself or paired with another drug, in people whose breast cancer has spread to the brain.
-
Two brain health programs tested for adults with brain tumors and their caregivers
This trial compares two programs meant to support thinking skills and brain health.
-
Testing a vaccine made from a person's own cells, along with standard treatment for new glioblastoma
This trial tests adding a vaccine, made for each person, to the usual first treatment for glioblastoma.
-
A vaccine made from a person's own cells, added to other glioblastoma treatment
This trial tests a vaccine made from a person's own cells for a brain tumor.
-
Testing metformin for thinking and brain growth in children after brain tumor treatment
This trial tests a drug called metformin in young people who finished brain tumor treatment.
-
A study of a drug called NEO212 for brain tumors and cancer that has spread to the brain
This trial is testing a drug called NEO212 in people whose brain tumor has grown, and in people whose cancer has spread to the brain.
-
A study tracking spine tumor surgery followed by radiation in adults
This study follows adults who have spine tumor surgery and then radiation.
-
A study of immune changes after glioblastoma surgery and treatment
This study looks at how the body's immune system changes after brain tumor surgery and treatment.
-
Age Related Thresholds for Management of Severe Head Injury in Paediatrics: An Extension of STARSHIP
From the trial team: Traumatic brain injury in children can cause serious and long-lasting neuro-disability. However, there is still limited evidence about the best ways to treat children with severe brain injury in intensive care.
-
Testing a treatment plan for children and young adults with NGGCT brain tumors
This trial tests how to match chemotherapy and radiation to how well a tumor responds to early treatment.
-
Testing how focused sound waves change the fluid around a brain tumor
This study looks at how focused sound waves change the fluid around a brain tumor.
-
Testing obinutuzumab as ongoing treatment for brain and spinal cord lymphoma
It tests a drug given after brain or spinal cord lymphoma responds to treatment.
-
Testing three treatments together for glioblastoma that has come back
This study tests whether three treatments can be given together safely.
-
Gallium maltolate taken by mouth for glioblastoma that has come back
This trial checks whether a drug taken by mouth reaches brain tumor tissue.
-
Testing Cesium-131 GammaTiler for Older or Frail Adults With Glioma
This study looks at whether a treatment called GammaTiler is safe for older or frail people with a glioma brain tumor.
-
Brain training with live brain scans for childhood medulloblastoma survivors
This study tests if watching your own brain at work can help with memory and focus after a childhood brain tumor.
-
A study of thinking and memory after proton therapy for brain tumors
This trial looks at how proton therapy affects thinking and memory in people with brain tumors.
-
A study of pituitary gland tumors in children
This study looks at children with pituitary gland tumors and tries to learn what causes them.
Trial information comes from ClinicalTrials.gov, a service of the U.S. National Library of Medicine. We copy it as it is published there and do not change it. Always check the trial's own page for the latest.